Arrhythmic sudden death in children

Archives of Cardiovascular Diseases

Volumn 101, Issue 2, 2008, Pages 121-125

  Denjoy, I ^a,b,c   Lupoglazoff, J M ^a,c   Guicheney, P ^c   Leenhardt, A ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c INSERM   (France)

Author keywords

Brugada; Cardiomyopathy; Channelopathy; Sudden death

Indexed keywords

AJMALINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALSEQUESTRIN; CALSEQUESTRIN 2; DIHYDROQUINIDINE; FLECAINIDE; NADOLOL; SODIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

BRUGADA SYNDROME; CARDIOMYOPATHY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHANNELOPATHY; DEFIBRILLATOR; DIAGNOSTIC PROCEDURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; GENE MUTATION; HEART DISEASE; HEART VENTRICLE ARRHYTHMIA; HIGH RISK POPULATION; HUMAN; LONG QT SYNDROME; PARENT; PEDIATRICS; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRENATAL PERIOD; QT INTERVAL; REVIEW; SHORT QT SYNDROME; SIBLING; SUDDEN DEATH; SURVIVAL; SYMPTOM; SYNCOPE;

EID: 41549140063     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1875-2136(08)70269-9     Document Type: Review

References (19)

1. Wren C. Sudden death in children and adolescents. Heart 2002;88:426-31.
2. Silka MJ. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998;32:245-51.
3. Gatzoulis MA. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot : a multicentre study. Lancet 2000;256:975-81.
4. Watkins H. Sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000;342:422-4.
5. Muller G, Ulmer H, Hagel K, Wolf D. Cardiac dysarrhythmias in children with idiopathic dilated or hypertrophic cardiomyopathy. Pediatr Cardiol 1995;16:56-60.
6. Lupoglazoff JM, Denjoy I, Guicheney P. Apports de la géné tique dans la prise en charge du syndrome du QT long congénital. Arch Mal Coeur 2003;96:539-47.
7. Zareba W, Moss AJ, Schwartz PJ, et al. Influence of the genotype on the clinical course of the long-QT syndrome. N Eng J Med 1998;339 :960-5.
8. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype phenotype correlation in the long QT syndrome: specific triggers for life-threatening arrhythmias. Circulation 2001;103:89-95.
9. Lupoglazoff JM, Denjoy I, Villain E, et al. Long QT syndrome in neonates. J Am Coll Cardiol 2004;43:826-30.
10. Maron BJ, Chaitman BR, Ackerman MJ, et al. Recommandations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 2004;109:2807-16.
11. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995;91:1512-9.
12. Denjoy I, Postma A, Lupoglazoff JM ,et al. Tachycardies ventriculaires catécholergiques chez l'enfant. Arch Mal Coeur 2005;98:506-12.
13. Laitinen PJ, Brown KN, Piippo K, et al. Mutations of Cardiac Ryanodine Receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001;103:485-90.
14. Postma A, Denjoy I, Hoorntje TM, et al. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res 2002;91:e21-e26.
15. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST segment elevation in leads V1 through V3. A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998;97:457-0.
16. Wilde A, Antzelevitvh C, Borggrefe M, et al. Proposed diagnosistic criteria for Brugada syndrome : consensus report. Circulation 2002 ; 106 :2514-19.
17. Probst V, Denjoy I, Meregalli P, et al. Clinical aspects and prognosis of Brugada syndrome in children. Circulation 2007 115: 2042-48.
18. Brugada R, Hong K, Dumaine R, et al. Sudden death associated with short QT syndrome linked to mutations in HERG. Circulation 2004;109:30-5.
19. Lupoglazoff JM, Denjoy I. Syndrome du QT court familial. Rev Prat 2007;57:121-5.